NFE2L2 and atherosclerosis: These conflicting results suggest the need to focus on the role of unknown functions of Nrf2 signaling pathway in hyperlipidemia, atherosclerosis, gout, and other inflammation-related diseases, which could enable the discovery of new therapeutics based on this pathway.